Biden Administration Accused of Manipulating Data on Chemical Abortion Pills, Says HHS Secretary.

Health and Human Services Secretary, Robert F. Kennedy Jr, claimed that data for the chemical abortion pill, mifepristone, was misrepresented by the Biden administration to obscure related safety issues. This was revealed during an FDA review on safety protocols for the drug. Kennedy assured that the inaccuracies would be corrected moving forward, promising the delivery of honest science-based data.

Pro-life advocates hope that the FDA will reinstate the drug’s safety standards to protect women whereas abortion proponents maintain that the safety regulations restrict access to the drug and assert that mifepristone is safe.

The pill is currently under review after an analysis of insurance claims from 2017 to 2023 presented mifepristone as being 22 times more dangerous than previously assumed from FDA data. Around 11% of women experienced serious side effects such as sepsis, infection, and hemorrhaging within 45 days of drug intake.

The article also discussed the FDA’s safety program, REMS (Risk Evaluation and Mitigation Strategies), used for medications with severe safety concerns. Only 74 drugs from the over 20,000 FDA-approved prescription drugs are considered dangerous enough to require REMS restrictions, one of them being mifepristone.

Up to 32 women have died as a result of using mifepristone between its approval in 2000 and 2022, according to FDA data. Experts claim that delivering deceased children at home or under non-medical supervision is common, and women are often unprepared for this situation. Pro-life concerns also include the likelihood of the drug being used in human trafficking and other abusive situations.